Search | VHL Search Portal

1.

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.

Marcus, Robert; Davies, Andrew; Ando, Kiyoshi; Klapper, Wolfram; Opat, Stephen; Owen, Carolyn; Phillips, Elizabeth; Sangha, Randeep; Schlag, Rudolf; Seymour, John F; Townsend, William; Trnený, Marek; Wenger, Michael; Fingerle-Rowson, Günter; Rufibach, Kaspar; Moore, Tom; Herold, Michael; Hiddemann, Wolfgang.

N Engl J Med ; 377(14): 1331-1344, 2017 10 05.

Article in English | MEDLINE | ID: mdl-28976863

2.

Undiagnosed cardiac deficits in non-small cell carcinoma patients in the candidate population for anti-cachexia clinical trials.

Kazemi-Bajestani, Seyyed Mohammad Reza; Becher, Harald; Butts, Charles; Basappa, Naveen S; Smylie, Michael; Joy, Anil Abraham; Sangha, Randeep; Gallivan, Andrea; Chu, Quincy; Baracos, Vickie E.

Support Care Cancer ; 27(4): 1551-1561, 2019 Apr.

Article in English | MEDLINE | ID: mdl-30547303

3.

Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.

Palanca-Wessels, Maria Corinna A; Czuczman, Myron; Salles, Gilles; Assouline, Sarit; Sehn, Laurie H; Flinn, Ian; Patel, Manish R; Sangha, Randeep; Hagenbeek, Anton; Advani, Ranjana; Tilly, Herve; Casasnovas, Olivier; Press, Oliver W; Yalamanchili, Sreeni; Kahn, Robert; Dere, Randall C; Lu, Dan; Jones, Surai; Jones, Cheryl; Chu, Yu-Waye; Morschhauser, Franck.

Lancet Oncol ; 16(6): 704-15, 2015 Jun.

Article in English | MEDLINE | ID: mdl-25925619

4.

A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors.

Chu, Quincy Siu-Chung; Sangha, Randeep; Spratlin, Jennifer; Vos, Larissa J; Mackey, John R; McEwan, Alexander J B; Venner, Peter; Michelakis, Evangelos D.

Invest New Drugs ; 33(3): 603-10, 2015 Jun.

Article in English | MEDLINE | ID: mdl-25762000

5.

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial.

Ellis, Peter M; Shepherd, Frances A; Millward, Michael; Perrone, Francesco; Seymour, Lesley; Liu, Geoffrey; Sun, Sophie; Cho, Byoung Chul; Morabito, Alessandro; Leighl, Natasha B; Stockler, Martin R; Lee, Christopher W; Wierzbicki, Rafal; Cohen, Victor; Blais, Normand; Sangha, Randeep S; Favaretto, Adolfo G; Kang, Jin Hyoung; Tsao, Ming-Sound; Wilson, Carolyn F; Goldberg, Zelanna; Ding, Keyue; Goss, Glenwood D; Bradbury, Penelope Ann.

Lancet Oncol ; 15(12): 1379-88, 2014 Nov.

Article in English | MEDLINE | ID: mdl-25439692

6.

A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors.

Chu, Quincy S; Sangha, Randeep; Hotte, Sebastien J; Sergenson, Gwen; Schnell, David; Chand, Vikram K; Hirte, Hal W.

Invest New Drugs ; 32(6): 1226-35, 2014 Dec.

Article in English | MEDLINE | ID: mdl-25037863

7.

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors.

Cook, Sarah; Samuel, Vanessa; Meyers, Daniel E; Stukalin, Igor; Litt, Ishjot; Sangha, Randeep; Morris, Don G; Heng, Daniel Y C; Pabani, Aliyah; Dean, Michelle; Navani, Vishal.

JAMA Netw Open ; 7(1): e2352302, 2024 Jan 02.

Article in English | MEDLINE | ID: mdl-38236598

8.

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer.

Ho, Cheryl; Davies, Angela M; Sangha, Randeep S; Lau, Derick; Lara, Primo; Chew, Helen K; Beckett, Laurel; Mack, Philip C; Riess, Jonathan W; Gandara, David R.

Invest New Drugs ; 31(6): 1587-91, 2013 Dec.

Article in English | MEDLINE | ID: mdl-24013936

9.

Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade.

Navani, Vishal; Meyers, Daniel E; Ruan, Yibing; Boyne, Devon J; O'Sullivan, Dylan E; Dolter, Samantha; Grosjean, Heidi Ai; Stukalin, Igor; Heng, Daniel Y C; Morris, Don G; Brenner, Darren R; Sangha, Randeep; Cheung, Winson Y; Pabani, Aliyah.

Clin Lung Cancer ; 24(3): e152-e159, 2023 05.

Article in English | MEDLINE | ID: mdl-36774234

10.

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.

Brahmer, Julie R; Lee, Jong-Seok; Ciuleanu, Tudor-Eliade; Bernabe Caro, Reyes; Nishio, Makoto; Urban, Laszlo; Audigier-Valette, Clarisse; Lupinacci, Lorena; Sangha, Randeep; Pluzanski, Adam; Burgers, Jacobus; Mahave, Mauricio; Ahmed, Samreen; Schoenfeld, Adam J; Paz-Ares, Luis G; Reck, Martin; Borghaei, Hossein; O'Byrne, Kenneth J; Gupta, Ravi G; Bushong, Judith; Li, Li; Blum, Steven I; Eccles, Laura J; Ramalingam, Suresh S.

J Clin Oncol ; 41(6): 1200-1212, 2023 02 20.

Article in English | MEDLINE | ID: mdl-36223558

11.

TIME for a successful cancer vaccine in NSCLC?

Butts, Charles A; Sangha, Randeep.

Lancet Oncol ; 17(2): 131-132, 2016 Feb.

Article in English | MEDLINE | ID: mdl-26727164

12.

Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma.

Sangha, Randeep; Davies, Neal M; Namdar, Afshin; Chu, Michael; Spratlin, Jennifer; Beauchamp, Erwan; Berthiaume, Luc G; Mackey, John R.

Curr Oncol ; 29(3): 1939-1946, 2022 03 13.

Article in English | MEDLINE | ID: mdl-35323358

13.

Expected Cost Savings From Low-Dose Computed Tomography Scan Screening for Lung Cancer in Alberta, Canada.

Thanh, Nguyen Xuan; Pham, Truong-Minh; Waye, Arianna; Tremblay, Alain; Yang, Huiming; Dean, Michelle L; Wasylak, Tracy; Sangha, Randeep; Stewart, Douglas.

JTO Clin Res Rep ; 3(7): 100350, 2022 Jul.

Article in English | MEDLINE | ID: mdl-35769390

14.

Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort.

Gibson, Amanda J W; Box, Adrian; Cheung, Winson Y; Dean, Michelle L; Elegbede, Anifat A; Hao, Desiree; Pabani, Aliyah; Sangha, Randeep; Bebb, Dafydd Gwyn.

Curr Oncol ; 29(3): 1967-1982, 2022 03 14.

Article in English | MEDLINE | ID: mdl-35323360

15.

Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.

Nastoupil, Loretta J; Kuruvilla, John; Chavez, Julio C; Bijou, Fontanet; Witzig, Thomas E; Santoro, Armando; Flinn, Ian W; Boccomini, Carola; Kenkre, Vaishalee P; Corradini, Paolo; Isufi, Iris; Andorsky, David J; Klein, Leonard M; Greenwald, Daniel R; Sangha, Randeep; Shen, Frank; Hagner, Patrick; Li, Yan; Dobmeyer, Juergen; Gong, Nian; Uttamsingh, Shailaja; Pourdehnad, Michael; Ribrag, Vincent.

EJHaem ; 3(2): 394-405, 2022 May.

Article in English | MEDLINE | ID: mdl-35846031

16.

Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.

Ribrag, Vincent; Chavez, Julio C; Boccomini, Carola; Kaplan, Jason; Chandler, Jason C; Santoro, Armando; Corradini, Paolo; Flinn, Ian W; Advani, Ranjana; Cassier, Philippe A; Sangha, Randeep; Kenkre, Vaishalee P; Isufi, Iris; Uttamsingh, Shailaja; Hagner, Patrick R; Gandhi, Anita K; Shen, Frank; Michelliza, Sophie; Haeske, Harald; Hege, Kristen; Pourdehnad, Michael; Kuruvilla, John.

EJHaem ; 3(1): 139-153, 2022 Feb.

Article in English | MEDLINE | ID: mdl-35846221

17.

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial.

Paz-Ares, Luis G; Ramalingam, Suresh S; Ciuleanu, Tudor-Eliade; Lee, Jong-Seok; Urban, Laszlo; Caro, Reyes Bernabe; Park, Keunchil; Sakai, Hiroshi; Ohe, Yuichiro; Nishio, Makoto; Audigier-Valette, Clarisse; Burgers, Jacobus A; Pluzanski, Adam; Sangha, Randeep; Gallardo, Carlos; Takeda, Masayuki; Linardou, Helena; Lupinacci, Lorena; Lee, Ki Hyeong; Caserta, Claudia; Provencio, Mariano; Carcereny, Enric; Otterson, Gregory A; Schenker, Michael; Zurawski, Bogdan; Alexandru, Aurelia; Vergnenegre, Alain; Raimbourg, Judith; Feeney, Kynan; Kim, Sang-We; Borghaei, Hossein; O'Byrne, Kenneth John; Hellmann, Matthew D; Memaj, Arteid; Nathan, Faith Ellen; Bushong, Judith; Tran, Phuong; Brahmer, Julie R; Reck, Martin.

J Thorac Oncol ; 17(2): 289-308, 2022 02.

Article in English | MEDLINE | ID: mdl-34648948

18.

Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I study.

Ho, Cheryl; Sangha, Randeep; Beckett, Laurel; Tanaka, Michael; Lau, Derick H; Eisen, Daniel B; Burich, Rachel A; Luciw, Paul; Khan, Imran; Mack, Philip C; Gandara, David R; Davies, Angela M.

Invest New Drugs ; 29(4): 680-7, 2011 Aug.

Article in English | MEDLINE | ID: mdl-20148348

19.

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors.

Gibson, Amanda J W; Box, Adrian; Dean, Michelle L; Elegbede, Anifat A; Hao, Desiree; Sangha, Randeep; Bebb, D Gwyn.

JTO Clin Res Rep ; 2(4): 100157, 2021 Apr.

Article in English | MEDLINE | ID: mdl-34590010

20.

Adjuvant therapy in non-small cell lung cancer: current and future directions.

Sangha, Randeep; Price, Julie; Butts, Charles A.

Oncologist ; 15(8): 862-72, 2010.

Article in English | MEDLINE | ID: mdl-20682608

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: